ICYMI: NEW SURVEY FINDS VOTERS CONTINUE TO BLAME BIG PHARMA FOR OUT-OF-CONTROL DRUG PRICES, SUPPORT CONGRESSIONAL ACTION

Patients for Affordable Drugs Now Poll Finds Vast Majority of Voters Reject… Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

J&J Beats Q1 Earnings Expectations, Announces Dividend Increase After… Read More

ICYMI: THE NEW YORK TIMES EDITORIAL BOARD ENDORSES SOLUTIONS TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE

Highlights How Administration and Lawmakers Can Fix Loopholes Exploited by… Read More

CSRXP: FINALIZED CMS COVERAGE DECISION FOR ADUHELM PROTECTS SENIORS AND TAXPAYERS FROM BIG PHARMA PRICE-GOUGING

Decision Appropriately Balances Access to Treatment with the Need for More… Read More

BIG PHARMA WATCH: BRANDED DRUG COMPANIES MORE THAN DOUBLED PRICES FOR BLOCKBUSTER BLOOD THINNING MEDICATIONS OVER TEN YEARS

New Report Demonstrates How Brand Name Drug Companies Work in “Lockstep”… Read More

DOSE OF REALITY: NEW STUDY FINDS ONE THIRD OF SENIORS DO NOT FILL PRESCRIPTIONS FOR HIGH-PRICE DRUGS USED TO TREAT SERIOUS CONDITIONS

Academic Study Underscores How Big Pharma’s Price-Gouging on Treatments for… Read More

THEY SAID IT! FINANCE COMMITTEE HIGHLIGHTS URGENCY TO HOLD BIG PHARMA ACCOUNTABLE FOR PRICE HIKES AND ANTI-COMPETITIVE BEHAVIOR

Lawmakers Double-Down on Repeated Promises to the American People to Lower… Read More

DOSE OF REALITY: LAWMAKERS MUST HOLD BIG PHARMA ACCOUNTABLE IN SENATE FINANCE HEARING

Congress Can Refocus Attention on Market-Based Solutions to Crack Down on… Read More

ICYMI: HEALTH CARE LEADERS LAUNCH LOW-COST INSULIN INITIATIVE

Non-Profit and Private Sector Partners Work Together to Help Provide Relief… Read More

ICYMI: NEW REPORT SHOWS REBATES NOT TIED TO LIST PRICE INCREASES

Matrix Global Advisors Report Further Undermines Big Pharma’s Supply Chain… Read More

CSRXP COMMENDS PRESIDENT BIDEN FOR RENEWING COMMITMENT TO LOWERING DRUG PRICES, CONGRESS MUST ACT

Lawmakers Must Deliver on Repeated Promises to Hold Big Pharma Accountable… Read More

BIG PHARMA WATCH: STUDY FINDS DRUG COMPANIES HIKED PRICES FASTER THAN INFLATION ON 23 OF TOP 25 MOST POPULAR MEDICARE PART D DRUGS

KFF Analysis Shows Big Pharma’s Price Hikes Outpaced Inflation for Half of… Read More

© 2026 CSRXP- All Rights Reserved